Ceftozect S 250mg/125mg Injection
Marketer
Adegen Pharma Private Limited
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ceftozect S 250mg/125mg Injection
Ceftriaxone and Sulbactam 250mg/125mg injection is a dual-action antibiotic. It's used to combat a range of bacterial infections by inhibiting microbial growth and propagation. This injection must be administered only by a qualified healthcare provider. Strictly adhere to your prescribed dosage schedule; completing the full course is vital, even with symptom improvement. Premature cessation can compromise treatment efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects to your doctor promptly. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, breathing difficulties). Inform your physician of all current medications, especially if you are pregnant, breastfeeding, or have pre-existing health conditions. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't affect driving ability, refrain from driving if experiencing dizziness or somnolence. Adequate rest, proper nutrition, and hydration are recommended for optimal recovery. Your doctor may order blood tests or other diagnostics to monitor treatment response.
Uses of Ceftozect S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Ceftozect S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ceftozect S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftozect S 250mg/125mg Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Ceftozect S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Ceftozect S 250mg/125mg Injection, offer a dual-action antibacterial approach. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant use of Ceftozect S 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Ceftozect S 250mg/125mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; however, clinical data in humans is scarce.
Breast feedingCAUTION
Administering Ceftozect S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Ceftozect S 250mg/125mg Injection may induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Ceftozect S 250mg/125mg Injection administration to individuals with renal impairment. Seek medical advice.
LiverCAUTION
The injectable medication Ceftozect S 250mg/125mg requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Altering the Ceftozect S 250mg/125mg Injection dose is generally not suggested for patients experiencing mild or moderate liver dysfunction.
What if you forget to take Ceftozect S 250mg/125mg Injection :
Omitting a scheduled dose of Ceftozect S 250mg/125mg Injection necessitates contacting your physician.
Facts to Know About Ceftozect S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobials |
3,018 People bought this recently